Article
Health-related quality-of-life in a randomized phase III first-line study of gefitinib versus carboplatin/paclitaxel in clinically selected patients from Asia with advanced NSCLC (IPASS).
Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer - 1 Nov 2011
Thongprasert Sumitra, Duffield Emma, Saijo Nagahiro, Wu Yi-Long, Yang James Chih-Hsin, Chu Da-Tong, Liao Meilin, Chen Yuh-Min, Kuo Han-Pin, Negoro Shunichi, Lam Kwok Chi, Armour Alison, Magill Patrick, Fukuoka Masahiro
Abstract excerpt
INTRODUCTION: Evaluation of health-related quality-of-life (HRQoL) and symptom improvement were preplanned secondary objectives for the overall population and posthoc analyses for epidermal growth factor receptor (EGFR) mutation-positive/negative subgroups in IPASS. METHODS: HRQoL was assessed us...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.